BH3-MIMETIC TREATMENT REVEALS SUBTYPE-SPECIFIC BCL-2 PROTEIN DEPENDENCY IN PEDIATRIC MDS WITH EXCESS BLASTSSheila Bohler, Miriam Erlacher, Beat Bornhäuser et al.|EJC Paediatric Oncology|2025Cited by 0
INTEGRATED IMMUNOPHENOTYPING AND DRUG RESPONSE PROFILING REVEALS SUBTYPE-SPECIFIC SUSCEPTIBILITIES IN PEDIATRIC MDS WITH EXCESS BLASTSNastassja Scheidegger-Egloff, Beat Bornhäuser, Silvia Gutnik et al.|EJC Paediatric Oncology|2025Cited by 0